How to Buy Wave Life Sciences Stock
Wave Life Sciences Ltd
Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform.
Wave Life Sciences stock last closed at $8.61, up 4.24% from the previous day, and has increased 52.12% in one year. It has overperformed other stocks in the Biotechnology industry by 0.64 percentage points. Wave Life Sciences stock is currently +146% from its 52-week low of $3.50, and -13.21% from its 52-week high of $9.92.
At the moment, there are 124.74M shares of WVE outstanding. The market capitalization of WVE is $1.07B. In the last 24 hours, 915,959 WVE shares were traded.
How to Buy Wave Life Sciences Stock
Not sure how to invest in Wave Life Sciences stock? Here's how.
- Choose where to buy Wave Life Sciences stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Wave Life Sciences stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your method of payment and add your details.
- Research Wave Life Sciences stock: The Wave Life Sciences ticker symbol is WVE. Is Wave Life Sciences stock a good investment? Should you buy shares of WVE? How do WVE's underlying business fundamentals look? Do top analysts think Wave Life Sciences is a good buy? Why has WVE's stock price moved recently? (Hint: Our stock research website can help you evaluate if WVE is a good stock to buy).
- Place your WVE trade: Decide if you will purchase WVE shares at the current market price or use a limit order to buy WVE shares at a particular price.
- Keep an eye on your investment in WVE: Create a watchlist to get the latest news on your new investment in Wave Life Sciences stock.
Step 1: Choose where to buy Wave Life Sciences stock
You need an online brokerage account to access the NASDAQ market and buy WVE shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Energy, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, you need to fill out some personal information so you are able to invest in WVE today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app, your next step is to transfer the money for your investment:
Watch the video below for more details transferring money into your investment account.
Step 4: Research Wave Life Sciences stock
After you have identified the best place to buy Wave Life Sciences stock, it's absolutely critical to analyze their stock prior to investing, so you truly understand the risk and upside.
Wave Life Sciences quick stats
WVE Zen Score
WallStreetZen was built to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on WVE's stock page.
Is WVE stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge WVE's fair value.
You can do additional valuation analysis on WVE's stock here.
How do WVE Financials look?
Positive Financial Indicators:
- WVE has cash burn of 129619000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the WVE balance sheet.
Negative Financial Indicators:
- WVE has $153.96M in cash and short term investments. This is not enough to cover its annual cash burn of $129.62M.
- Total WVE debt is still negative.
- WVE debt to equity ratio of -58.79 is negative.
- WVE profit margin has gone up by 2.92 percentage points in the past year, but the company is still unprofitable.
- There are more short-term liabilities than short-term assets on the WVE balance sheet.
Is it a good time to buy WVE stock, according to Wall Street analysts?
Out of 7 Wall Street analysts who track WVE, the consensus analyst rating on Wave Life Sciences is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest WVE Analyst Ratings
An analyst from JP Morgan initiates coverage on WVE with a strong buy rating and announces their WVE price target of $10.00, on Sep 9, 2024.
Salim Syed, a bottom 12% analyst from Mizuho reiterates WVE with a buy rating and maintains their WVE price target from $19.00 to $19.00, on Jun 25, 2024.
Tiago Fauth, a bottom 5% analyst from Wells Fargo initiates coverage on WVE with a strong buy rating and announces their WVE price target of $11.00, on May 15, 2024.
You can dig deeper into what analysts are saying on the Wave Life Sciences stock forecast page.
WVE Technical Indicators
WVE Performance Metrics
Last year, WVE revenue was $110.50M. During the last five year, WVE's revenue has increased by 42.56% per year. This was slower than the Biotechnology industry average of 58.59%.
Find out more about WVE's earnings and revenue performance here.
Who is buying/selling WVE?
Over the last year, insiders at WVE have bought more shares than they have sold.
Gsk PLC, 10% Owner of WVE, was the latest WVE insider to buy. They bought $22,335,440.00 worth of WVE shares on Sep 27, 2024.
Dig into more about who owns WVE stock here.
Can I get consistent income from WVE stock?
No, Wave Life Sciences doesn't provide an income stream by paying out dividends.
WVE Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your WVE trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.
Click the Open button and eToro will place your order.
If you want more help with investing in stocks on eToro, click the how to video below:
Step 6: Keep an eye on your investment in WVE
Now that you own some shares in WVE, you'll want to stay up-to-date on your company.
Make a watchlist to get notified of the latest news about your WVE stock.
WVE Feed
How to Buy Stock in Wave Life Sciences
To reiterate, here are the 6 steps you need to take to buy Wave Life Sciences stock right now:
- Choose where to buy Wave Life Sciences stock
- Create a brokerage account
- Fund your brokerage account
- Research Wave Life Sciences stock
- Place your WVE trade
- Keep an eye on your investment in WVE
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to track your investment in Wave Life Sciences, get started below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.